‘Very Important’ Mechanism of Action Discovered for Levosimendan

‘Very Important’ Mechanism of Action Discovered for Levosimendan

302950

‘Very Important’ Mechanism of Action Discovered for Levosimendan

Levosimendan, an investigational treatment for pulmonary hypertension and heart failure with preserved ejection fraction, or PH-HFpEF — which showed positive results in a recent clinical trial — may work by reducing the amount of blood putting pressure on the walls of blood vessels, a new analysis suggests. The findings were published in the Journal of Cardiac Failure, in a study titled “Changes in Stressed Blood Volume with Levosimendan in Pulmonary Hypertension from Heart Failure with Preserved…

You must be logged in to read/download the full post.